Neutral Effect on Markers of Heart Failure, Inflammation, Endothelial Activation and Function, and Vagal Tone After High-Dose HMG-CoA Reductase Inhibition in Non-Diabetic Patients With Non-Ischemic Cardiomyopathy and Average Low-Density Lipoprotein Level

Publication | Closed Access

DOI

Citations

References

2005

Year

Barry E. Bleske, John M. Nicklas, Robert L. Bard, Robert D. Brook, Paul A. Gurbel, Kevin P. Bliden, Sanjay Rajagopalan, Bertram Pitt

Journal of the American College of Cardiology

Metabolic SyndromeHeart FailureCardiovascular DiseaseAtherosclerosisMedicinePhysiologyDiabetesVagal ToneVascular BiologyHyperlipidemiaPharmacologyCardiologyNeutral EffectDyslipidemiaOxidative StressHealth Sciences